1. Introduction
1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:
4. North America Medical Perfusion Technology Market Landscape
4.1 Market Overview
4.2 Porter's Five Forces Analysis
- 4.2.1 Bargaining Power of Suppliers
- 4.2.2 Bargaining Power of Buyers
- 4.2.3 Threat of New Entrants
- 4.2.4 Competitive Rivalry
- 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
- 4.3.1 Raw Material Suppliers
- 4.3.2 Manufacturers
- 4.3.3 Distributors/Suppliers
- 4.3.4 End Users
5. North America Medical Perfusion Technology Market – Key Market Dynamics
5.1 Growth Drivers
- 5.1.1 Rising Prevalence of Cardiovascular ConditionsIncreasing Practice of Organ Transplantation
5.2 Market Opportunities
- 5.2.1 Perfusion Instruments for Cell-based Research Activities
5.3 Future Trends
- 5.3.1 Growth Opportunities in Emerging Nations
5.4 Impact of Drivers and Restraints
6. North America Medical Perfusion Technology Market Regional Analysis
6.1 North America Medical Perfusion Technology Market Overview
6.2 North America Medical Perfusion Technology Market Revenue 2017-2027 (US$ Million)
6.3 North America Medical Perfusion Technology Market Forecast Analysis
7. North America Medical Perfusion Technology Market Analysis – by Technique
7.1 Hypothermic Machine Perfusion
- 7.1.1 Overview
- 7.1.2 Hypothermic Machine Perfusion: North America Medical Perfusion Technology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Normothermic Machine Perfusion
- 7.2.1 Overview
- 7.2.2 Normothermic Machine Perfusion: North America Medical Perfusion Technology Market – Revenue and Forecast to 2031 (US$ Million)
8. North America Medical Perfusion Technology Market Analysis – by Organ Type
8.1 Heart
- 8.1.1 Overview
- 8.1.2 Heart: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Lung
- 8.2.1 Overview
- 8.2.2 Lung: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Kidney
- 8.3.1 Overview
- 8.3.2 Kidney: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Liver
- 8.4.1 Overview
- 8.4.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
9. North America Medical Perfusion Technology Market Analysis – by Component
9.1 Perfusion Pumps
- 9.1.1 Overview
- 9.1.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Oxygenators
- 9.2.1 Overview
- 9.2.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Heart-Lung Machines
- 9.3.1 Overview
- 9.3.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
9.4 Monitoring Systems
- 9.4.1 Overview
- 9.4.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
9.5 Cannulas
- 9.5.1 Overview
- 9.5.2 Liver: North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
10. North America Medical Perfusion Technology Market – North America Analysis
10.1 North America
- 10.1.1 North America Medical Perfusion Technology Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 10.1.1.1 North America Medical Perfusion Technology Market – Revenue and
Forecast Analysis – by Country
- 10.1.1.1 US:
North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.1.1 US: North America Medical Perfusion Technology Market Breakdown, by Technique
- 10.1.1.1.2 US: North America Medical Perfusion Technology Market Breakdown, by Organ Type
- 10.1.1.1.3 US: North America Medical Perfusion Technology Market Breakdown, by Component
- 10.1.1.2 Canada:
North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.2.1 Canada: North America Medical Perfusion Technology Market Breakdown, by Technique
- 10.1.1.2.2 Canada: North America Medical Perfusion Technology Market Breakdown, by Organ Type
- 10.1.1.2.3 Canada: North America Medical Perfusion Technology Market Breakdown, by Component
- 10.1.1.3 Mexico :
North America Medical Perfusion Technology Market – Revenue and Forecast to 2027 (US$ Million)
- 10.1.1.3.1 Mexico : North America Medical Perfusion Technology Market Breakdown, by Technique
- 10.1.1.3.2 Mexico : North America Medical Perfusion Technology Market Breakdown, by Organ Type
- 10.1.1.3.3 Mexico : North America Medical Perfusion Technology Market Breakdown, by Component
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. North America Medical Perfusion Technology Market Industry Landscape
12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments
13. Company Profiles
13.1 Medtronic
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 LivaNova PLC
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Terumo Corporation
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 XVIVO Perfusion
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 OrganOx Limited
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Waters Medical Systems LLC
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 TransMedics
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Organ Recovery Systems
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 Xenios AG - a Fresenius Medical Care company
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights